Evidence map›Paper›PMID 31965184›Full record

ArticleNucleic acids research2020

The landscape of chimeric RNAs in non-diseased tissues and cells.

Sandeep Singh, Fujun Qin, Shailesh Kumar, Justin Elfman, Emily Lin, Lam-Phong Pham, Amy Yang, Hui Li

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Science advances · 2026
    Article
  4. Article
  5. Review
  6. Induction of ferroptosis in prostate cancer by CCDC7Cell death and differentiation · 2026
    Article
  7. Article
  8. Article
  9. Assembly of a Full-Length Chimeric RNA Transcriptome.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  10. Calculating Relative Chimeric RNA Expression with FusionBlaster.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  11. Integrative Chimeric RNA Prediction with FASfuse.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Sandeep SinghDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Fujun QinDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Shailesh KumarNational Institute of Plant Genome Research (NIPGR), New Delhi 110067, India.
Justin ElfmanDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Emily LinDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Lam-Phong PhamDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Amy YangDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Hui LiDepartment of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
University of Virginia · USNational Institute of Plant Genome Research · IN

Funding

Training in Cell and Molecular BiologyT32GM139787 · NIGMS · UNIVERSITY OF VIRGINIA · PI Bryce Paschal · 2021 to 2026
$2.5M
Induction of Gene Fusions by Pre-Existing Chimeric TranscriptsR01CA190713 · NCI · UNIVERSITY OF VIRGINIA · PI LI, HUI · 2014 to 2018
$1.8M
Genome-wide Investigation of cis-splicing between Adjacent Genes NOSI Admin SupplementR01GM132138 · NIGMS · UNIVERSITY OF VIRGINIA · PI LI, HUI · 2019 to 2022
$1.4M
NCI NIH HHS R01 CA190713NIGMS NIH HHS R01 GM132138NIGMS NIH HHS T32 GM139787
6 · The paper itself

Abstract

Chimeric RNAs and their encoded proteins have been traditionally viewed as unique features of neoplasia, and have been used as biomarkers and therapeutic targets for multiple cancers. Recent studies have demonstrated that chimeric RNAs also exist in non-cancerous cells and tissues, although large-scale, genome-wide studies of chimeric RNAs in non-diseased tissues have been scarce. Here, we explored the landscape of chimeric RNAs in 9495 non-diseased human tissue samples of 53 different tissues from the GTEx project. Further, we established means for classifying chimeric RNAs, and observed enrichment for particular classifications as more stringent filters are applied. We experimentally validated a subset of chimeric RNAs from each classification and demonstrated functional relevance of two chimeric RNAs in non-cancerous cells. Importantly, our list of chimeric RNAs in non-diseased tissues overlaps with some entries in several cancer fusion databases, raising concerns for some annotations. The data from this study provides a large repository of chimeric RNAs present in non-diseased tissues, which can be used as a control dataset to facilitate the identification of true cancer-specific chimeras.

Indexed as

BiomarkersChimeraHumansNeoplasmsRNABiomarkersRNA

Identifiers

PMID31965184
PMCPMC7038929
OpenAlexW3002469446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.